Mapping the Functional Assessment of Cancer Therapy - Breast (FACT-B) to the 5-level EuroQoL group's 5-dimension questionnaire (EQ-5D-5L) utility index in a Multi-ethnic Asian population

Health and Quality of Life Outcomes

Volumn 12, Issue 1, 2014, Pages

  Cheung, Yin Bun ^a,b,c   Luo, Nan ^d   Ng, Raymond ^e   Lee, Chun Fan ^a,b  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b SINGAPORE CLINICAL RESEARCH INSTITUTE   (Singapore)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Breast cancer; EQ 5D 5L; FACT B; Health utility; Mapping; Quality of life

Indexed keywords

ADULT; ALGORITHM; ARTICLE; BREAST CANCER; CANCER THERAPY; DEPRESSION; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY BREAST; HEALTH CARE POLICY; HEALTH CARE SURVEY; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGIST; QUALITY OF LIFE; QUESTIONNAIRE; SECONDARY ANALYSIS; SELF CARE; TEST RETEST RELIABILITY; VISUAL ANALOG SCALE; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; CAUCASIAN; CHINA; ETHNIC GROUP; ETHNOLOGY; INDIA; INFORMATION PROCESSING; MALAYSIA; MIDDLE AGED; PSYCHOLOGICAL MODEL; PSYCHOLOGY; REGRESSION ANALYSIS; SINGAPORE; SOCIAL PARTICIPATION;

ADULT; ALGORITHMS; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHINA; DATA COLLECTION; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS; HUMANS; INDIA; MALAYSIA; MIDDLE AGED; MODELS, PSYCHOLOGICAL; QUALITY OF LIFE; REGRESSION ANALYSIS; SINGAPORE; SOCIAL PARTICIPATION; SURVEYS AND QUESTIONNAIRES;

EID: 84924756428     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/s12955-014-0180-6     Document Type: Article

References (35)

1. National Institute for Health and Clinical Excellence: Guide to the methods of technology appraisal 2013. Available at https://www.nice.org.uk/article/pmg9/resources/non-guidance-guide-to-the-methods-of-technology-appraisal-2013-pdf. accessed 13 December 2014.
2. Longworth L, Rowen D: NICE DSU Technical Support Document 10: the Use of Mapping Methods to Estimate Health State Utility Values. Sheffield: Decision Support Unit, ScHARR, University of Sheffield; 2011. Available at http://www.nicedsu.org.uk/TSD%2010%20mapping%20FINAL.pdf. accessed 6 March 2014.
3. Longworth L, Rowen D: Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health 2013, 16:202-210.
4. Dakin H: Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes 2013, 11:151.
5. Cella D: FACIT Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Evanston, IL: CORE; 1997.
6. Webster K, Cella D, Yost K: The Functional Assessment of Chronic Illness Therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 2003, 1:79.
7. Cheung YB, Thumboo J, Gao F, Ng GY, Pang G, Koo WH, Sethi VK, Wee J, Goh C: Mapping the English and Chinese versions of the functional assessment of cancer therapy-general to the EQ-5D utility index. Value Health 2009, 12(2):371-376.
8. Wu EQ, Mulani P, Farrell MH, Sleep D: Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value Health 2007, 10:408-414.
9. Askew RL, Swartz RJ, Xing Y, Cantor SB, Ross MI, Gershenwald JE, Palmer JL, Lee JE, Cormier JN: Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Health 2011, 14:900-906.
10. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
11. Lee CF, Luo N, Ng R, Wong NS, Yap YS, Lo SK, Chia WK, Yee A, Krishna L, Wong C, Goh C, Cheung YB: Comparison of the Measurement properties between a short and generic instrument, the 5-level EuroQoL Group's 5-Dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy - Breast (FACT-B), in Asian breast cancer patients. Qual Life Res 2013, 22:1745-1751.
12. Wan C, Zhang D, Yang Z, Tu X, Tang W, Feng C, Wang H, Tang X: Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat 2007, 106:413-418.
13. Brady M, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G: Reliability and validity of the functional assessment of cancer therapy - breast quality-of-life instrument. J Clin Oncol 1997, 15:974-986.
14. Ng R, Lee CF, Wong NS, Luo N, Yap YS, Lo SK, Chia WK, Yee A, Krishna L, Goh C, Cheung YB: Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy - Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat 2012, 131:619-625.
15. Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D: Evaluating equivalency between response systems application of the Rasch model to a 3-level and 5-level EQ-5D. Med Care 2007, 45:812-819.
16. Lee CF, Ng R, Luo N, Wong NS, Yap YS, Lo SK, Chia WK, Yee A, Krishna L, Wong C, Goh C, Cheung YB: The English and Chinese versions of the 5-level EuroQoL Group's 5-dimension questionnaire (EQ-5D) were valid and reliable and provided comparable scores in Asian breast cancer patients. Support Care Cancer 2013, 21:201-209.
17. van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS: Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3 L value sets. Value Health 2012, 15:708-715.
18. Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, Hamashima C, Hisashige A, Tamura M: Estimating an EQ-5D population value set: the case of Japan. Health Econ 2002, 11:341-353.
19. Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J: Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. J Clin Oncol 2005, 23:4936-4944.
20. Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D: Performance status score: do patients and their oncologists agree? Br J Cancer 2003, 89:1022-1027.
21. Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C: Observer error in grading performance status in cancer patients. Support Care Cancer 1999, 7:332-335.
22. Austin PC: A comparison of methods for analyzing health-related quality-of-life measures. Value Health 2002, 5:329-337.
23. Powell JL: Least absolute deviations estimation for the censored regression model. J Econometrics 1984, 25:303-325.
24. Pullenayegum EM, Tarride JE, Xie F, Goeree R, Gerstein HC, O'Reilly D: Analysis of health utility data when some subjects attain the upper bound of 1: Are Tobit and CLAD models appropriate? Value Health 2010, 13:487-494.
25. Austin PC, Tu JV, Daly PA, Alter DA: The use of quantile regression in health care research: a case study examining gender differences in the timeliness of thrombolytic therapy. Stat Med 2005, 24:791-816.
26. Bottai M, Cai B, McKeown RE: Logistic quantile regression for bounded outcomes. Stat Med 2010, 29:309-317.
27. Orsini N, Bottai M: Logistic quantile regression in Stata. Stata J 2011, 11:327-344.
28. Sullivan PW, Ghushchyan V: Mapping the EQ-5D index from the SF-12: US geneneral population preferences in a nationally representative sample. Med Decis Making 2006, 26:401-409.
29. Cuzick J: A Wilcoxon-type test for trend. Stat Med 1985, 4:87-90.
30. Chuang LH, Kind P: Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics 2009, 27:491-505.
31. Cheung YB, Tan LCS, Lau PN, Au WL, Luo N: Mapping the eight-item Parkinson's disease questionnaire (PDQ-8) to the EQ-5D utility index. Qual Life Res 2008, 17:1173-1181.
32. Brazier JE, Yang Y, Tsuchiya A, Rowen DL: A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ 2010, 11:215-225.
33. Pickard AS, Neary MP, Cella D: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 2007, 5:70.
34. Cheung YB, Thumboo J: Developing health-related quality-of-life instruments for use in Asia: the issues. Pharmacoeconomics 2006, 24:643-650.
35. Sakthong P, Charoenvisuthiwongs R, Shabunthom R: A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health Qual Life Outcomes 2008, 6:71.